Neurocrine Biosciences, Inc. Share Price

Neurocrine Biosciences, Inc. Share Price

NASDAQ: NBIX | Large Cap
$146.44
+$0.98 (0.67%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Neurocrine Biosciences, Inc. Stock Performance

Open
$146.59
Prev. Close
$145.47
Circuit Range
N/A
Day Range
$145.38 - $146.85
Year Range
$122.17 - $186.10
Volume
39,359
Average Traded
$146.08

Neurocrine Biosciences, Inc. Share Price Today

As of 30 October 2026, Neurocrine Biosciences, Inc.'s share price is $146.44. The stock opened at $146.59, compared to its previous close of $145.47. During today's trading session, Neurocrine Biosciences, Inc.'s share price traded between $145.38 and $146.85, with an average price of $146.12. Over the past 52 weeks, the stock has recorded a high of $186.10 and a low of $122.17. In terms of performance, Neurocrine Biosciences, Inc.'s share price has risen by 11.12% over the last six months and is up 2.28% on a year-on-year basis.

Neurocrine Biosciences, Inc. Share Price Chart

Line chart of the Neurocrine Biosciences, Inc. price trend over the selected period. The price rose overall, ranging from 145.38 to 146.96, ending at 146.44.
$145.38$146.85
L
Show Current Price
H

Neurocrine Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$14.57B
PE Ratio (TTM)
20.97
Dividend Yield
0.00%
EPS (TTM)
$6.94
Revenue (TTM)
$2.86T
Return On Equity (TTM)
19.10%
Profit Margin
16.73%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-31.07%

Neurocrine Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$794.90$805.50$814.50$959.00
Net Profit$209.50$153.70$197.90$144.40
Net Profit Margin26.36%19.08%24.30%15.06%
Income ChangeN/A-26.63%28.76%-27.03%

Neurocrine Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1488.70$1887.10$2355.30$2860.50
Net Profit$154.50$249.70$341.30$478.60
Net Profit Margin10.38%13.23%14.49%16.73%
Income ChangeN/A61.62%36.68%40.23%

About Neurocrine Biosciences, Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Neurocrine Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$141.31
$146.47
+3.12%
Sep 2026
$155.56
$142.03
-8.95%
Aug 2026
$167.70
$155.99
-6.46%
Jul 2026
$168.57
$166.76
-0.99%
Jun 2026
$159.50
$168.42
+6.36%
May 2026
$132.03
$158.35
+20.15%
Apr 2026
$132.47
$131.79
+0.05%
Mar 2026
$131.82
$131.73
-0.35%
Feb 2026
$136.25
$132.19
-2.87%
Jan 2026
$141.42
$136.09
-4.01%
Dec 2025
$151.39
$141.77
-6.85%
Nov 2025
$143.70
$152.19
+6.29%

NBIX Share Price FAQs